VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares were up 70.6% during mid-day trading on Thursday . The stock traded as high as C$0.15 and last traded at C$0.15. Approximately 3,410,212 shares were traded during mid-day trading, an increase of 1,439% from the average daily volume of 221,520 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Price Performance
The firm has a market capitalization of C$18.65 million, a P/E ratio of -3.55 and a beta of 0.39. The business’s fifty day moving average is C$0.10 and its 200 day moving average is C$0.13. The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of -58.56.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- P/E Ratio Calculation: How to Assess Stocks
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Best Stocks Under $5.00
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
